Skip to content

Biomarkers of Whole Grain Wheat and Rye Intake

Urinary Alkylresorcinol Metabolites as a Biomarker of Whole Grain Wheat and Rye Intake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02155062
Enrollment
10
Registered
2014-06-04
Start date
2014-05-31
Completion date
2014-09-30
Last updated
2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Nutritional biomarker, Dietary assessment, Whole grain, Wheat, Rye, Alkylresorcinol, Urine

Brief summary

Alkylresorcinols (AR) are a group of lipids found in the bran fraction of wheat and rye grains. AR are absorbed into the bloodstream and their metabolites are excreted in urine in measurable amounts following ingestion of wholegrain (WG) wheat or rye cereal. As AR are absent in refined cereals, plasma AR and urinary AR metabolites are proposed as suitable biomarkers of dietary intake of WG wheat and rye cereal, with a number of studies supporting this proposal. Different AR species are present in characteristic quantities in WG wheat in comparison to WG rye cereals, which can allow identification of the main source of WG (wheat or rye) in individuals by analysing the AR concentrations in blood. However the patterns of urinary AR metabolite excretion following wheat or rye intake have not yet been investigated to determine if there are differences according to WG source. The present study aims to: (i) investigate the differences in AR metabolite excretion pattern in spot and 24 hour urine samples after following a predominantly WG rye-based diet in comparison to a predominantly WG wheat-based diet and in comparison to control (refined cereal diet) (ii) compare the validity and reproducibility of AR metabolites in spot urine samples in comparison to 24 hour urine samples.

Interventions

OTHERRefined cereal

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass intake 18.5-30.0 kg/m2 * Weight stable for 2 months * Generally healthy

Exclusion criteria

* Previous or current chronic disease including heart disease, diabetes, gastrointestinal, liver, renal or endocrine disorders * Drug or alcohol misuse in the last year * Current pregnancy or lactation * Weight change of \>3 kg in the last two months * Current regular user of certain prescription medications (except contraceptives) * Unwilling to consume or to stop consuming WG wheat, WG rye or refined cereals * Unwilling to discontinue multivitamins/dietary supplements during study

Design outcomes

Primary

MeasureTime frameDescription
24-h urinary DHBA:DHPPA ratioEndpoint (Day 3)DHBA: 3,5-dihydroxybenzoic acid DHPPA: 3-(3,5-dihydroxyphenyl)-propanoic acid DHBA & DHPPA are the main AR metabolites excreted in urine

Secondary

MeasureTime frame
24-h urinary DHPPA:creatinine ratioEndpoint (Day 3)
24-h urinary total AR (DHBA+DHPPA):creatinine ratioEndpoint (Day 3)
DHBA:DHPPA ratio in morning spot urineEndpoint (Day 3)
Total 24-h urinary AR metabolite (DHBA + DHPPA) excretionEndpoint (Day 3)
24-h urinary DHBA:creatinine ratioEndpoint (Day 3)
Total 24-h urinary DHPPA excretionEndpoint (Day 3)
Total AR (DHBA+DHPPA):creatinine ratio in morning spot urine sampleEndpoint (Day 3)
DHBA:creatinine ratio in morning spot urine sampleEndpoint (Day 3)
DHPPA:creatinine ratio in morning spot urine sampleEndpoint (Day 3)
Total 24-h urinary DHBA excretionEndpoint (Day 3)

Other

MeasureTime frame
Estimated daily intake of WG wheat and rye cerealsAssessed throughout each intervention period (Days 1-3)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026